Pappas Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8

- Investments
-
154
- Portfolio
-
18
- Exits
-
77

Pappas Capital General Information
Description
Founded in 1994, Pappas Capital is a venture capital firm based in Durham, North Carolina. The firm seeks to invest in companies based in the United States and Canada operating in the life sciences, biotechnology, biopharmaceuticals, drug delivery and medical devices sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Primary Office
- 2520 Meridian Parkway
- Suite 400
- Durham, NC 27713
- United States
+1 (919) 000-0000
Pappas Capital Investments (154)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Aktis Oncology | 18-Aug-2022 | Early Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials | |
0000000 | 03-Jun-2022 | 00000 00000 | 0000 | Decision/Risk Analysis | Generating Revenue | |
0000000 000000 | 01-Jun-2022 | 00000 00000 | 0000 | Clinics/Outpatient Services | Generating Revenue/Not Profitable | |
000.00 | 14-Apr-2022 | 00000 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | |
0000000 | 28-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Startup | |
000000 000 | 05-Jan-2022 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
00000000000 | 22-Dec-2021 | 00000 00000 | 00.000 | Business/Productivity Software | Generating Revenue | |
0000000 0000000000 | 22-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | |
Istari Oncology | 19-Apr-2021 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - General | |
Reneo | 16-Mar-2021 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | 000000 000000 |
Pappas Capital Exits (77)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Amplyx Pharmaceuticals | 28-Apr-2021 | Merger/Acquisition | |
00000 | 09-Apr-2021 | 000 | 000.00 |
0000000 | 10-Mar-2021 | 000000000000000000 | 000.00 |
00000000 | 18-Dec-2020 | 000000000000000000 | 00.00 |
0000000 | 16-Dec-2020 | 000 | 00000 |
0000 | 11-Dec-2020 | 000 | 00000 |
0000000 0000000000 | 28-Oct-2020 | 000 00 00000000 | |
0000000000 | 01-May-2020 | 0000000000 | |
Curzion Pharmaceuticals | 01-Apr-2020 | Merger/Acquisition | 0000 |
Mirum Pharmaceuticals | 18-Jul-2019 | IPO | 0000 |
Pappas Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Pappas Capital Investments by Industry, Year, and Region
Pappas Capital Team (49)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Matthew Boyer | Chief Financial Officer | Durham, NC | |||
Arthur Pappas | Managing Partner | 00 | 0 | 0 | Durham, NC |
Barry Myers Ph.D | Venture Partner | Durham, NC | |||
Miranda Gottlieb | Venture Partner | Durham, NC | |||
Peter Young | Venture Partner | 0 | Durham, NC |
Pappas Capital Co-Investors (108)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
New Enterprise Associates | 5 | 0 | 0 |
![]() |
![]() |
Chiesi Ventures | 0 | 0 | 0 |
![]() |
![]() |
RiverVest Venture Partners | 0 | 0 | 0 |
![]() |
![]() |
Lundbeckfond Ventures | 0 | 0 | 0 |
![]() |
![]() |
Novo Holdings | 0 | 0 |
![]() |
![]() |